Health

Tags:

NIH-supported researchers find link between allergen in red meat and heart disease

A team of researchers says it has linked sensitivity to an allergen in red meat to the buildup of plaque in the arteries of the heart. While high saturated fat levels in red meat have long been known to contribute to heart disease for people in general, the new finding suggests that a subgroup of the population may be at heightened risk for a different reason – a food allergen.

Tags:

Veterinary medicines: new EU rules to enhance availability and fight against antimicrobial resistance

On 13 June 2018 EU ambassadors meeting in the Committee of Permanent Representatives (Coreper) confirmed an agreement reached on 5 June between the Bulgarian Presidency of the Council and European Parliament representatives on a regulation on veterinary medicines.

Tags:

NIH study finds no significant link between brain injury and IV fluid treatment of pediatric diabetic ketoacidosis

Giving children intravenous (IV) fluids to treat diabetic ketoacidosis — an emergency complication of untreated diabetes — does not appear to worsen the brain swelling that may accompany the condition, according to a study supported by the National Institutes of Health. The findings, published in the New England Journal of Medicine, contrast with widespread concern that providing too much IV fluid may result in serious brain injury.

Tags:

Everyone has 'a moral imperative' to uphold the rights of persons with disabilities, says UN chief

image1170x530cropped_114_0_0.jpg
UN Secretary-General António Guterres (centre) at the opening of the 11th Session of the Conference of States Parties to the Convention on the Rights of Persons with Disabilities.

Tags:

Nearly 40 Percent of Rohingya Children in Cox’s Bazar are Stunted: New Study

Humanitarian agencies supporting Rohingya refugees who fled to Bangladesh are making progress in improving children's health—but the situation remains critical, a new assessment by nutrition experts, including Save the Children, reveals.

Tags:

Youth tobacco use drops during 2011-2017

Yet 3.6 million middle and high school students still use tobacco products

Fewer U.S. middle and high school students are using tobacco products – but too many still do, according to a new survey published by the Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products.

Tags:

Suicide rates rising across the U.S.

Comprehensive prevention goes beyond a focus on mental health concerns

Suicide rates have been rising in nearly every state, according to the latest Vital Signs report by the Centers for Disease Control and Prevention (CDC). In 2016, nearly 45,000 Americans age 10 or older died by suicide. Suicide is the 10th leading cause of death and is one of just three leading causes that are on the rise.

Tags:

Eosinophilic esophagitis may be due to missing protein

NIH-funded study finds replacement therapy reversed effects in tissue experiments.

Scientists have discovered that the absence of a specific protein in cells lining the esophagus may cause inflammation and tissue damage in people with eosinophilic esophagitis (EoE). EoE affects as many as 150,000 people in the United States, many of whom are children. People with EoE experience difficult or painful swallowing, vomiting and nutritional problems because an accumulation of immune cells called eosinophils (link is external) scars the esophagus.

Tags:

EPA Reaches Settlement with Magnolia Homes for Alleged Lead Paint Violations During Renovations Depicted on the Fixer Upper Television Show

The U.S. Environmental Protection Agency (EPA) and Magnolia Waco Properties, LLC, which does business as Magnolia Homes, have reached a settlement to resolve alleged violations of the Toxic Substances Control Act (TSCA) Lead Renovation, Repair and Painting Rule (RRP Rule), related to home renovations conducted without adequate lead paint protections as depicted on the television program Fixer Upper.

Tags:

New approach to immunotherapy leads to complete response in breast cancer patient unresponsive to other treatments

A novel approach to immunotherapy developed by researchers at the National Cancer Institute (NCI) has led to the complete regression of breast cancer in a patient who was unresponsive to all other treatments. This patient received the treatment in a clinical trial led by Steven A. Rosenberg, M.D., Ph.D., chief of the Surgery Branch at NCI’s Center for Cancer Research (CCR), and the findings were published June 4, 2018 in Nature Medicine. NCI is part of the National Institutes of Health.